Development of pemphigus foliaceus in a patient with psoriasis: A simple coincidence?

European Journal of Dermatology

Volumn 8, Issue 1, 1998, Pages 56-59

  Tomasini, Dario ^a   Cerri, Amilcare ^b   Cozzani, Emanuele ^c   Berti, Emilio ^d  

^a BUSTO ARSIZIO HOSPITAL   (Italy)

^b S Paul Hospital   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmune diseases; Disease association; Immunoblot technique; Pathogenetic mechanisms; Pemphigus foliaceus; Psoriasis vulgaris

Indexed keywords

AGED; ARTICLE; AUTOIMMUNE DISEASE; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; PATHOGENESIS; PEMPHIGOID; PEMPHIGUS FOLIACEUS; PSORIASIS; PSORIASIS VULGARIS;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, NEEDLE; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PREDNISONE; PROGNOSIS; PSORIASIS;

EID: 0031746887     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Weber PJ, Salazar JE. Bullous eruption in a psoriatic patient. Arch Dermatol 1989; 125: 690-4.
2. Grunwald MH, David M, Feuerman EJ. Coexistence of psoriasis vulgaris and bullous diseases. J Am Acad Dermatol 1985; 13: 224-8.
3. Fryer EJ, Lebwohl M. Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. J Am Acad Dermatol 1994; 30: 651-3.
4. Hashimoto T, Ogawa MM, Nishikawa T. Detection of pemphigus vulgaris and pemhigus foliaceus antigens by immunoblot analysis using different antigen sources. J Invest Dermatol 1990; 94: 327-31.
5. Eyre RW, Stanley JR. Human auto-antibodies against a desmosomal protein complex with a calcium-sensitive epitope are characteristic of pemphigus foliaceus antigen. J Exp Med 1987; 165: 1719-25.
6. Leoni A. Quadro a tipo di pemfigo foliaceo in corso di psoriasi. Min Dermatol 1952; 27: 238-40.
7. De Lestrade MB. Constatation temporaine du signe de Nikolsky au cours d'une pousse érythrodermique compliquant un psoriasis pustuleux. Valeurs? Bull Soc Fr Dermatol Syph 1959; 65: 796-8.
8. Jaimovich L, de Kaminsky AR, Intebi D, et al. Coexistence of psoriasis and pemphigus erythematosus. Derm Internat 1965; 4: 143-6.
9. Scherak O, Kolarz G, Holubar K. Pemphigus erythematosus-like rash in a patient on penicillamine. Br Med J 1977; 1: 838-9.
10. Kennedy C, Hodge L, Sanderson KV. Skin changes caused by D-penicillamine treatment of arthritis. Clin Exp Dermatol 1978; 3: 107-16.
11. Fye KH, Tanenbaum L. Penicillamine-induced pemphigus vulgaris in psoriasis arthritis. J Rheumatol 1982; 9: 331-2.
12. Lee CW, Ro YS, Kim JH, et al. Concurrent development of pemphigus foliaceus and psoriasis. Int J Dermatol 1985; 24: 316-7.
13. Yokoo M, Oka D, Ueki H. Coexistence of psoriasis vulgaris and pemphigus foliaceus. Dermatologica 1989; 179: 222-3.
14. Lee CW, Ro YS. Pemphigus developed on preexisting dermatoses. J Dermatol 1994; 21: 213-5.
15. Perez GI, Agger WA, Abellera RM, Dahlberg P. Pemphigus foliaceus coexisting with IgA nephropathy in a patient with psoriasis vulgaris. Int J Dermatol 1995; 34: 794-6.
16. Pisanti S, Sharav Y, Kaufman E, Posner LN. Pemphigus vulgaris: incidence in Jews of different ethnic groups according to age, sex, and initial lesion. Oral Surg Oral Med Oral Pathol 1974; 38: 382-93.
17. Scharf SJ, Friedmann A, Brautbar C, et al. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA 1988; 85: 3504-8.
18. Ruocco V, Rossi A Astarita C, et al. An abortive form of pemphigus vulgaris probably induced by penicillin. Dermatologica 1979; 159: 266-73.
19. Kaplan RP, Callen JP. Pemphigus-associated diseases and induced pemphigus. Clin Dermatol 1983; 1: 42-71.
20. Dourmishev AL, Rahamn MA. Phenobarbital-induced pemphigus vulgaris. Dermatologica 1986; 173: 256-68.
21. Wolf R, Dechner E, Ophir J, et al. Cephalexin. a nonthiol drug that may induce pemphigus vulgaris. Int J Dermatol 1991; 30: 213-5.
22. Maize JC, Dobson RL, Provst TT. Pemphigus and myasthenia gravis. Arch Dermatol 1975; 111: 1334-9.
23. Wolf R, Feuerman EJ. Pemphigus in association with autoimmune thyroid disease. Cutis 1981; 27: 423-31.
24. Mackie RM, Saikia NK, Morley WN. A case of pemphigus vulgaris in association with addisonian pernicious anemia. Br J Dermatol 1973; 88: 139-41.
25. Senear FE, Usher B. An unusual type of pemphigus combining features of lupus erythematosus. Arch Dermatol Syph 1926; 13: 761-81.
26. Anahlt GJ, Kim SC, Stanley JR, et al. Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia. N Engl J Med 1990; 323: 1729-35.
27. Christophers E, Sterry W. Psoriasis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM Austen KF eds. Dermatology in General Medicine 4th ed; New York, McGraw-Hill, 1992; 489-514.
28. Baker BS, Fry L The immunology of psoriasis. Br J Dermatol 1992; 126: 1-9.
29. Obalek S, Haftek M, Glinski W. Immunologic studies in psoriasis. Dermatologica 1977; 155: 13-33.
30. Krueger GG, Hill HR, Jederberg WW. Inflammatory and immune functioning psoriasis - a subtle disorder. I. In vivo-in vitro survey 1978; 70: 105-10.
31. Beutner EH, Jablonslca S, Jarzabek-Chorzelska M, et al. Studies in immunodermatology. IF studies of autoantibodies to the stratum corneum and of in vivo fixed IgG in stratum corneum of psoriatic lesions. Int Arch Allergy Appl Immunol 1975; 48: 301-23.
32. Cormane Rh, Hunyadi J, Harmelimk F. The role of lymphoid cells and polymorphonuclear leukocytes in the pathogenesis of psoriasis. J Dermatol (Tokyo) 1976; 3: 245-59.
33. Millns JL, Muller SA. The coexistence of psoriasis and lupus erythematosus. An analysis of 27 cases. Arch Dermatol 1980; 116: 658-63.
34. Brand CA, Littlejohn GB. Psoriatic arthritis and myasthenia gravis. J Dermatol 1984; 11: 2-44.
35. Nogita T, Aramoto Y, Terajima S, et al. The coexistence of psoriasis vulgaris, Sjogren's syndrome and Hashimoto's thyroiditis. J Dermatol 1992, 19: 302-5.
36. Yates VM, Watkinson G, Kelman A. Further evidence for an association between psoriasis, Crohn's disease and ulcerative colitis. Br J Dermatol 1982; 106: 323-30.
37. Fraki JE, Lazarus GS, Gilgor RS, et al. Correlation of epidermal plasminogen activator activity in psoriasis. Br J Dermatol 1983; 108: 39-44.
38. Hashimoto K, Wun TC, Baird JC, et al. Characterization of keratinocyte plasminogen activator inhibitors and demonstration of the prevention oT pemphigus IgG-induced acantholysis by a purified plasminogen activator inhibitor. J Invest Dermatol 1989; 92: 310-5.
39. Valdimarsson H, Sigmundsdottir H, Jonsdottir I. Is psoriasis induced by streptococcal superantigens and maintained by M-protein-specific T cells that cross-react with keratin? Clin Exp Immunol 1997; 107: 21-4.